| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Human Biological Chemistry and Genetics University of Texas Medical Branch Galveston, Texas 77550-0645
Glucocorticoids inhibit the proliferation of fibroblastic cells in vivo and in culture; however, the molecular mechanism that accounts for this effect has remained obscure. We have undertaken to elucidate the mechanism whereby glucocorticoids decrease the rate of proliferation of mouse L929 fibroblastic cells. Addition of dexamethasone to mid-log phase fibroblasts prolongs G1 phase. This increase in the G1 interval is associated with, and probably due to, inhibition of phosphorylation of the product of the Rb-1 tumor suppressor gene, pRb. Inhibition of pRb phosphorylation by cyclin D-dependent kinases can be demonstrated in vitro. Nevertheless, there is no detectable change in the expression of cyclin D1, cyclin D2, or cyclin D3. Cyclin-dependent kinase-4 (Cdk4) and Cdk6 are not down-regulated in L929 cells after addition of glucocorticoids, and the abundance of cyclin D/Cdk4 complexes does not change. Inhibition of pRb kinase activity is associated with an increase in the abundance of one of the Cdk inhibitors, p21Cip1. The abundance of another cyclin kinase inhibitor, p27Kip1, remains constant. The amount of Cdk4 that is bound to p21Cip1 increases rapidly after addition of dexamethasone, and the activity of Cdk4-pRb kinase decreases in parallel. These results indicate that glucocorticoid inhibition of fibroblast proliferation is due to induction of p21Cip1, which binds to and inactivates cyclinD/Cdk4 complexes. The abundance of p21 mRNA increases about 5-fold within 2 h after addition of dexamethasone. This effect does not obtain in L929 mutants that are null for the glucocorticoid receptor, and a variant that expresses the glucocorticoid receptor from a tetracycline-repressible expression vector demonstrates induction of p21 mRNA only in the absence of tetracycline. Cycloheximide does not block induction of p21 mRNA, and dexamethasone has no detectable effect on the apparent rate of degradation of p21 mRNA. Nuclear run-on transcription of the Cip1 gene increases within 2 h after addition of dexamethasone. This effect can be blocked by tetracycline-mediated repression of the glucocorticoid receptor.
This article has been cited by other articles:
 |
|
 |
|
  J.-Q. Yang, J. J. Rudiger, J. M. Hughes, S. Goulet, M. M. Gencay-Cornelson, P. Borger, M. Tamm, and M. Roth Cell Density and Serum Exposure Modify the Function of the Glucocorticoid Receptor C/EBP Complex Am. J. Respir. Cell Mol. Biol., April 1, 2008; 38(4): 414 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Lovgren, M. Kovarova, and B. H. Koller cPGES/p23 Is Required for Glucocorticoid Receptor Function and Embryonic Growth but Not Prostaglandin E2 Synthesis Mol. Cell. Biol., June 15, 2007; 27(12): 4416 - 4430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Harms, K. Albrecht, U. Harms, K. Seidel, L. Hauck, T. Baldinger, D. Hubner, G. Kronenberg, J. An, K. Ruscher, et al. Phosphatidylinositol 3-Akt-Kinase-Dependent Phosphorylation of p21Waf1/Cip1 as a Novel Mechanism of Neuroprotection by Glucocorticoids J. Neurosci., April 25, 2007; 27(17): 4562 - 4571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Igarashi, K. L. Medina, T. Yokota, M. I. D. Rossi, N. Sakaguchi, P. C. Comp, and P. W. Kincade Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids Int. Immunol., May 1, 2005; 17(5): 501 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Wang and M. J. Garabedian Modulation of Glucocorticoid Receptor Transcriptional Activation, Phosphorylation, and Growth Inhibition by p27Kip1 J. Biol. Chem., December 19, 2003; 278(51): 50897 - 50901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Urban, T. Golden, I. V. Aragon, L. Cowsert, S. R. Cooper, N. M. Dean, and R. E. Honkanen Identification of a Functional Link for the p53 Tumor Suppressor Protein in Dexamethasone-induced Growth Suppression J. Biol. Chem., March 7, 2003; 278(11): 9747 - 9753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Puddicombe, C. Torres-Lozano, A. Richter, F. Bucchieri, J. L. Lordan, P. H. Howarth, B. Vrugt, R. Albers, R. Djukanovic, S. T. Holgate, et al. Increased Expression of p21waf Cyclin-Dependent Kinase Inhibitor in Asthmatic Bronchial Epithelium Am. J. Respir. Cell Mol. Biol., January 1, 2003; 28(1): 61 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Greenberg, J. Hu, S. Basu, J. Hay, J. Reibman, T.-a. Yie, K. M. Tchou-Wong, W. N. Rom, and T. C. Lee Glucocorticoids Inhibit Lung Cancer Cell Growth through Both the Extracellular Signal-Related Kinase Pathway and Cell Cycle Regulators Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 320 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. CROCHEMORE, T. M. MICHAELIDIS, D. FISCHER, J.-P. LOEFFLER, and O. F. X. ALMEIDA Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation FASEB J, June 1, 2002; 16(8): 761 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Jensen, M. W. Madsen, J. Lukas, L. Binderup, and J. Bartek Inhibitory Effects of 1{alpha},25-Dihydroxyvitamin D3 on the G1-S Phase-Controlling Machinery Mol. Endocrinol., August 1, 2001; 15(8): 1370 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Sapolsky Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders Arch Gen Psychiatry, October 1, 2000; 57(10): 925 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Evans-Storms and J. A. Cidlowski Delineation of an Antiapoptotic Action of Glucocorticoids in Hepatoma Cells: The Role of Nuclear Factor-{kappa}B Endocrinology, May 1, 2000; 141(5): 1854 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. R. Samuelsson, A. Pazirandeh, B. Davani, and S. Okret p57Kip2, a Glucocorticoid-Induced Inhibitor of Cell Cycle Progression in HeLa Cells Mol. Endocrinol., November 1, 1999; 13(11): 1811 - 1822. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Quaroni, J. Q. Tian, M. Goke, and D. K. Podolsky Glucocorticoids have pleiotropic effects on small intestinal crypt cells Am J Physiol Gastrointest Liver Physiol, November 1, 1999; 277(5): G1027 - G1040. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Pestell, C. Albanese, A. T. Reutens, J. E. Segall, R. J. Lee, and A. Arnold The Cyclins and Cyclin-Dependent Kinase Inhibitors in Hormonal Regulation of Proliferation and Differentiation Endocr. Rev., August 1, 1999; 20(4): 501 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Rogatsky, A. B. Hittelman, D. Pearce, and M. J. Garabedian Distinct Glucocorticoid Receptor Transcriptional Regulatory Surfaces Mediate the Cytotoxic and Cytostatic Effects of Glucocorticoids Mol. Cell. Biol., July 1, 1999; 19(7): 5036 - 5049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Fernandes, E. Guida, V. Koutsoubos, T. Harris, P. Vadiveloo, J. W. Wilson, and A. G. Stewart Glucocorticoids Inhibit Proliferation, Cyclin D1 Expression, and Retinoblastoma Protein Phosphorylation, but Not Activity of the Extracellular-Regulated Kinases in Human Cultured Airway Smooth Muscle Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 77 - 88. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Sakai, T. Biwa, T. Matsumura, T. Takemura, H. Matsuda, Y. Anami, T. Sasahara, S. Kobori, and M. Shichiri Glucocorticoid Inhibits Oxidized LDL-Induced Macrophage Growth by Suppressing the Expression of Granulocyte/Macrophage Colony-Stimulating Factor Arterioscler Thromb Vasc Biol, July 1, 1999; 19(7): 1726 - 1733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Baghdassarian, A. Peiretti, E. Devaux, P. André Bryon, and M. Ffrench Involvement of p27Kip1 in the G1- and S/G2-phase Lengthening Mediated by Glucocorticoids in Normal Human Lymphocytes Cell Growth Differ., June 1, 1999; 10(6): 405 - 412. [Abstract] [Full Text]
|
|
|
|
|
|
O. Eickelberg, M. Roth, R. Lorx, V. Bruce, J. Rudiger, M. Johnson, and L.-H. Block Ligand-independent Activation of the Glucocorticoid Receptor by beta 2-Adrenergic Receptor Agonists in Primary Human Lung Fibroblasts and Vascular Smooth Muscle Cells J. Biol. Chem., January 8, 1999; 274(2): 1005 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Rogatsky, C. L. M. Waase, and M. J. Garabedian Phosphorylation and Inhibition of Rat Glucocorticoid Receptor Transcriptional Activation by Glycogen Synthase Kinase-3 (GSK-3). SPECIES-SPECIFIC DIFFERENCES BETWEEN HUMAN AND RAT GLUCOCORTICOID RECEPTOR SIGNALING AS REVEALED THROUGH GSK-3 PHOSPHORYLATION J. Biol. Chem., June 5, 1998; 273(23): 14315 - 14321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zuo, N. M. Dean, and R. E. Honkanen Serine/Threonine Protein Phosphatase Type 5 Acts Upstream of p53 to Regulate the Induction of p21WAF1/Cip1 and Mediate Growth Arrest J. Biol. Chem., May 15, 1998; 273(20): 12250 - 12258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. H. Cha, E. J. Cram, E. C. Wang, A. J. Huang, H. G. Kasler, and G. L. Firestone Glucocorticoids Stimulate p21 Gene Expression by Targeting Multiple Transcriptional Elements within a Steroid Responsive Region of the p21waf1/cip1 Promoter in Rat Hepatoma Cells J. Biol. Chem., January 23, 1998; 273(4): 1998 - 2007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Cram, R. A. Ramos, E. C. Wang, H. H. Cha, Y. Nishio, and G. L. Firestone Role of the CCAAT/Enhancer Binding Protein-alpha Transcription Factor in the Glucocorticoid Stimulation of p21waf1/cip1 Gene Promoter Activity in Growth-arrested Rat Hepatoma Cells J. Biol. Chem., January 23, 1998; 273(4): 2008 - 2014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Caelles, J. M. Gonzalez-Sancho, and A. Munoz Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway Genes & Dev., December 15, 1997; 11(24): 3351 - 3364. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
